Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease
- 1 July 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (2) , 362-368
- https://doi.org/10.1016/j.jacc.2004.03.065
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Angiotensin II Receptor–Independent Antiinflammatory and Antiaggregatory Properties of LosartanCirculation Research, 2002
- Risk of Myocardial Infarction and Angina in Patients With Severe Peripheral Vascular DiseaseCirculation, 2002
- Attenuation of atherogenesis by systemic and local adenovirus‐mediated gene transfer of interleukin‐10 in LDLr ‐/‐ MiceThe FASEB Journal, 2001
- IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes.Journal of Clinical Investigation, 1995
- Interleukin (IL)-10 Inhibits Nuclear Factor кB (NFкB) Activation in Human MonocytesJournal of Biological Chemistry, 1995
- Immunosuppressive and Anti-inflammatory Properties of Interleukin 10Annals of Medicine, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionNew England Journal of Medicine, 1991
- Platelet Activation in Unstable Coronary DiseaseNew England Journal of Medicine, 1986
- Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.Circulation, 1983